BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25105464)

  • 1. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
    Noel S; Zheng L; Navas-Acien A; Fuchs RJ
    Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
    Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S
    Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes.
    Eitas TK; Stepp WH; Sjeklocha L; Long CV; Riley C; Callahan J; Sanchez Y; Gough P; Knowlin L; van Duin D; Ortiz-Pujols S; Jones SW; Maile R; Hong Z; Berger S; Cairns BA
    PLoS One; 2017; 12(9):e0184164. PubMed ID: 28886135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.
    Tran TA; McCoy MK; Sporn MB; Tansey MG
    J Neuroinflammation; 2008 May; 5():14. PubMed ID: 18474101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
    Atilano-Roque A; Aleksunes LM; Joy MS
    Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
    Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
    J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
    Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
    Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
    Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
    Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway.
    Ahmed H; Amin U; Sun X; Pitts DR; Li Y; Zhu H; Jia Z
    Exp Biol Med (Maywood); 2022 Apr; 247(8):683-690. PubMed ID: 35034476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDDO-Me protects normal lung and breast epithelial cells but not cancer cells from radiation.
    El-Ashmawy M; Delgado O; Cardentey A; Wright WE; Shay JW
    PLoS One; 2014; 9(12):e115600. PubMed ID: 25536195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
    Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
    J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus.
    Kim MJ; Park H; Choi SH; Kong MJ; Kim JE; Kang TC
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of intracellular glutathione contributes to JNK-mediated death receptor 5 upregulation and apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me).
    Yue P; Zhou Z; Khuri FR; Sun SY
    Cancer Biol Ther; 2006 May; 5(5):492-7. PubMed ID: 16582599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
    Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Point Mutation at C151 of
    Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
    Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triterpenoid CDDO-Me induces ROS generation and up-regulates cellular levels of antioxidative enzymes without induction of DSBs in human peripheral blood mononuclear cells.
    Beinke C; Scherthan H; Port M; Popp T; Hermann C; Eder S
    Radiat Environ Biophys; 2020 Aug; 59(3):461-472. PubMed ID: 32409897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.